Earnings Call · Q4 FY2023·2024-02-29

Q4 23EPS +2.30%·Rev n/aQ3 23EPS -7.69%·Rev n/aQ2 23EPS +2.63%·Rev n/aQ1 23EPS -14.52%·Rev n/a⚠ consensus missing

Pacira BioSciences, Inc. PCRX

Susan Mesco — Head of Investor Relations

Frank Lee — Chief Executive Officer

Anthony Malloy — Chief Legal Counsel

Charles Reinhart — Chief Financial Officer

+5.7%1d on move date+5.6% vs SPY3d+7.1%5d+0.7%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PCRX calls or request research access.

More PCRX calls Browse calls Request research access